11.30
+0.038(+0.34%)
Currency In EUR
Address
Germany
Phone
N/A
Website
N/A
Sector
Financial Services
Industry
Asset Management
Employees
N/A
First IPO Date
February 23, 2018
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.